Advanced High-Grade Epithelial Ovarian Cancer
Oncology·MeSH: Fallopian Tube Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Mirvetuximab Soravtansine | AbbVie Inc. (ABBV) |
Frequently asked questions
How many drugs are in development for Advanced High-Grade Epithelial Ovarian Cancer?
BioSniper tracks 1 drug in development for Advanced High-Grade Epithelial Ovarian Cancer across 1 company.
How many clinical trials target Advanced High-Grade Epithelial Ovarian Cancer?
There are 1 clinical trial targeting Advanced High-Grade Epithelial Ovarian Cancer tracked by BioSniper.
Deep-dive into Advanced High-Grade Epithelial Ovarian Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis